{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:27:41Z","timestamp":1784060861461,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.taap.2012.08.018","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T22:45:51Z","timestamp":1345848351000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes"],"prefix":"10.1016","volume":"264","author":[{"given":"Jayakumar","family":"Surendradoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.08.018_bb0240","series-title":"Valproate","first-page":"47","article-title":"Chemistry and biotransformation","author":"Abbott","year":"1999"},{"key":"10.1016\/j.taap.2012.08.018_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2005.12.039","article-title":"Use of spectroscopic probes for detection of reactive oxygen species","volume":"368","author":"Bartosz","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.taap.2012.08.018_bb0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.freeradbiomed.2005.10.042","article-title":"The oxidation of 2\u2032,7\u2032-dichlorofluorescin to reactive oxygen species: a self-fulfilling prophesy?","volume":"40","author":"Bonini","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.08.018_bb0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/03602530600959433","article-title":"Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity","volume":"38","author":"Chang","year":"2006","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2012.08.018_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1124\/dmd.105.005751","article-title":"Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes","volume":"34","author":"Chang","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0030","first-page":"513","article-title":"Presence of a diffusional barrier on metabolite kinetics: enalaprilat as a generated versus preformed metabolite","volume":"14","author":"de Lannoy","year":"1986","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/toxsci\/kfn056","article-title":"In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone","volume":"103","author":"Dykens","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01962707","article-title":"Delta 2-valproate biotransformation using human liver microsomal fractions","volume":"14","author":"Fabre","year":"1992","journal-title":"Pharm. Weekbl. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jat.1420","article-title":"In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis","volume":"29","author":"Fujimura","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2012.08.018_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14656566.9.2.285","article-title":"Oral valproic acid for epilepsy \u2014 long-term experience in therapy and side effects","volume":"9","author":"Gerstner","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.taap.2012.08.018_bb0055","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0090-9556(24)15353-6","article-title":"Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals","volume":"28","author":"Gopaul","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0060","first-page":"1210","article-title":"Effect of \u03b1-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats","volume":"29","author":"Grillo","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0065","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1021\/bi00266a045","article-title":"Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes from rats treated with phenobarbital or \u03b2-naphthoflavone","volume":"21","author":"Guengerich","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2012.08.018_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity","volume":"32","author":"Jaeschke","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.taap.2012.08.018_bb0075","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/BF02618612","article-title":"Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes \u2014 freshly isolated cells, cell suspensions, and primary monolayer cultures","volume":"17","author":"Jauregui","year":"1981","journal-title":"In Vitro"},{"key":"10.1016\/j.taap.2012.08.018_bb9000","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0300-483X(96)03352-5","article-title":"Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes","volume":"112","author":"Jurima-Romet","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2012.08.018_bb0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0090-9556(25)08087-0","article-title":"Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations","volume":"21","author":"Kassahun","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0090-9556(25)07155-7","article-title":"Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans","volume":"19","author":"Kassahun","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2012.08.018_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfq294","article-title":"Role of oxidative metabolism in the effect of valproic acid on markers of cell viability, necrosis, and oxidative stress in sandwich-cultured rat hepatocytes","volume":"118","author":"Kiang","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.taap.2011.03.004","article-title":"Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: role of biotransformation and temporal relationship with onset of toxicity","volume":"252","author":"Kiang","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.08.018_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/clpt.1990.144","article-title":"Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid","volume":"48","author":"Levy","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2012.08.018_bb0115","first-page":"9","article-title":"Formation of hepatotoxic metabolites from 2-(E)-VPA in rats","volume":"32","author":"Lin","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2012.08.018_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0920-1211(92)90052-U","article-title":"Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies","volume":"13","author":"Loscher","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.taap.2012.08.018_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/abbi.1996.9752","article-title":"Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver","volume":"337","author":"Mahnke","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2012.08.018_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2011.03.010","article-title":"Unraveling the biological roles of reactive oxygen species","volume":"13","author":"Murphy","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2012.08.018_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-2952(93)90504-P","article-title":"Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in the rat and mouse","volume":"46","author":"Nerurkar","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.08.018_bb0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj1950761","article-title":"Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole","volume":"195","author":"Ortiz de Montellano","year":"1981","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2012.08.018_bb0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.spen.2010.06.006","article-title":"Medical management of refractory status epilepticus","volume":"17","author":"Owens","year":"2010","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.taap.2012.08.018_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0090-9556(25)07724-4","article-title":"Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes","volume":"12","author":"Pang","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0155","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","article-title":"In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions","volume":"43","author":"Ponchaut","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.08.018_bb0160","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.3101178","article-title":"Cytochrome P-450-catalyzed formation of delta4-VPA, a toxic metabolite of valproic acid","volume":"235","author":"Rettie","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.taap.2012.08.018_bb0165","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1021\/bi00024a013","article-title":"CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid","volume":"34","author":"Rettie","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2012.08.018_bb0170","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0175","first-page":"231","article-title":"Isolation of hepatocytes by collagenase perfusion","volume":"1A","author":"Seglen","year":"1993","journal-title":"Meth. Toxicol."},{"key":"10.1016\/j.taap.2012.08.018_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.taap.2012.08.018_bb0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.taap.2012.08.018_bb0190","first-page":"219","article-title":"A comparative investigation of 2-propyl-4-pentenoic acid (4-ene-VPA) and its a-fluorinated analogue: phase II metabolism and pharmacokinetics","volume":"25","author":"Tang","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/tx00047a006","article-title":"Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status","volume":"8","author":"Tang","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.08.018_bb0195","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0090-9556(25)07371-4","article-title":"Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases","volume":"24","author":"Tang","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.08.018_bb0205","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0891-5849(03)00151-5","article-title":"The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats","volume":"34","author":"Tong","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.08.018_bb0210","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfi185","article-title":"Valproic acid II: effect on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.freeradbiomed.2007.06.026","article-title":"Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects","volume":"43","author":"Wardman","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.08.018_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/abbi.1999.1351","article-title":"P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR","volume":"369","author":"Waxman","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2012.08.018_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.08.018_bb0230","unstructured":"Zheng, J.J., 1993. Metabolism and pharmacokinetic studies of valproic acid using stable isotope techniques. M.Sc. thesis. The University of British Columbia, Vancouver, Canada."},{"key":"10.1016\/j.taap.2012.08.018_bb0235","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:42:24Z","timestamp":1758573744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12003705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0041008X12003705"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.08.018","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2012.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}